What small company looks like it’s quietly preparing for something bigger?
u/ShaveMyPineapple ·
Reddit — r/ValueInvesting
· May 18, 2026 at 08:21
· ⬆ 15 pts
· 💬 63 comments
| View on Reddit ↗
AI Summary
Summary
The post asks for small-cap companies that appear to be quietly preparing for major moves (e.g., expanding projects, raising capital, hiring, partnerships).
Two community comments provide specific tickers: INTR (Inter & Co) with bullish fundamental metrics, and CMPS (Compass Pathways) as a potential paradigm shift in psychiatry.
Quality assessment: The post is a general discussion prompt (no original DD). The comment on INTR offers quantitative reasoning (PEG 0.3, ROE 15%, insider ownership); the CMPS comment is a brief personal thesis with credentials but lacks detailed data. Overall, these are speculative leads rather than rigorous DD.
Compass Pathways is developing psychedelic therapy for treatment-resistant depression. Commenter (MD/PhD) claims it may lead a paradigm shift. Small-cap biotech with a novel, high-potential pipeline; if FDA approval path clears, significant upside. A speculative early-stage biotech bet on a new treatment class; high risk/reward. Regulatory rejection, clinical trial failures, competitive landscape (e.g., MAPS), capital dilution.
INTR (Inter & Co) has forward P/E of 8, 5-year EPS growth estimate of +25%, PEG ~0.3, ROE 15% and increasing, insiders own 45%. These metrics suggest deep undervaluation relative to growth, while large insider ownership aligns management with shareholders. Recent sell-off in LatAm/financials creates a buying opportunity. A small-cap value play with strong fundamentals and insider alignment; potential for violent rebounds as seen historically. Continued weakness in Latin American markets; currency and political risk in Brazil; possible earnings miss or sector headwinds.
This Reddit post, published May 18, 2026,
features u/ShaveMyPineapple
discussing CMPS, INTR.
2 trade ideas extracted by AI with direction and confidence scoring.